| Tag | Content |
|---|
EnhancerAtlas ID | HS037-17950 |
Organism | Homo sapiens |
Tissue/cell | ESC |
Coordinate | chr19:36192950-36193820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59463 | chr19:36184851-36210443 | Ly3 | | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | GACGGGGTTT CACCATATTG GTCAGGCTGG TCTCGAACTC CTGACCTCAG GTGATCTGCC 60
CGCCTTAGCC TCCCAAAGTG CTGGGATTAC AGGCGTGAGC CACCACGTCC GGCCCCTTCC 120
CCCATTTTAG CGGTTTCGCT CCCTATCGGG GCCAGGGACG CCTCAGGCTG TCTCGGTCAG 180
GACCTACAGC TCCGGTTGTT GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC 240
CACCCCCATT CCTCCCCACT CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC GCGCACAACA 300
ACACTCCGCG CAGCGGGAAG GTACCGAACT CGCATCGCAG CCTGAAACTG CTCAACTAAG 360
CTCCCGCCCC GCTGCTCTCT GGTCAATCTA AAGCGAAGAC GAGCCTTAGG GCCAATCAGA 420
AGCGACAGCG GTGGAGTCAT GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC ATTGGCTATG 480
CTTGAGAACG AATCCCAGGC TAAGCCACTT AGAAAGGAGC GGAGCCAGCC AATCAGCGGT 540
GCAACCGCCG CGGGGGCCGG GCCAGAAGCC CCGCAGACAA GCACCTCGGG AGACTGGCGA 600
GGGGCGAGCT CGCAGCTTGT TAGCCCCGAA GCCCTGCCCA GGGGGAAACC CTGCTGGAGG 660
GAGTCTAACC CCCGGGCCAG TTAATGTTGG GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT 720
ATGGTTGGAG GTGGGAGTGC TGACACGTCC GCGCGCAGTT ACTCCTGGCT GAGCATACAG 780
TCGAGGTGGC AGTGGGAATT GGAAGTGCAA GTGTCACGCT GCCAATCACG GGGCAAGGCA 840
CTGCCCCCCT CTTGTGTCTT TCCTGTCCCT 870
|
